We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+11.73%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$999M
AUM Growth
+$93.9M
Cap. Flow
-$1.02M
Cap. Flow %
-0.1%
Top 10 Hldgs %
34.01%
Holding
322
New
24
Increased
68
Reduced
124
Closed
23

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$17.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$5.79M
3
MSFT icon
Microsoft
MSFT
+$5.26M
4
WELL icon
Welltower
WELL
+$5.16M
5
VOD icon
Vodafone
VOD
+$4.54M

Sector Composition

Rank Sector Weight
1 Technology 22.21%
2 Financials 15.18%
3 Consumer Discretionary 14.44%
4 Healthcare 10.91%
5 Industrials 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSP icon
1
Invesco S&P 500 Equal Weight ETF
RSP
$96.1B
$62.8M 6.29%
601,128
+392,452
+188% +$39.6M
GLW icon
2
Corning
GLW
$126B
$51.6M 5.17%
1,559,359
-5,666
-0.4% -$186K
INTC icon
3
Intel
INTC
$466B
$48.9M 4.89%
910,438
-8,488
-0.9% -$431K
AVY icon
4
Avery Dennison
AVY
$12.3B
$35.7M 3.57%
315,871
-902
-0.3% -$93.2K
CSCO icon
5
Cisco
CSCO
$450B
$27.8M 2.79%
515,645
-356,103
-41% -$17.3M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.07T
$26M 2.6%
129,209
-1,542
-1% -$311K
SON icon
7
Sonoco
SON
$5.76B
$22.7M 2.27%
368,966
-3,321
-0.9% -$191K
BMY icon
8
Bristol-Myers Squibb
BMY
$127B
$22.6M 2.26%
473,065
-116,262
-20% -$5.79M
JCI icon
9
Johnson Controls International
JCI
$87.5B
$21M 2.1%
567,374
-2,905
-0.5% -$99.7K
TXN icon
10
Texas Instruments
TXN
$255B
$20.6M 2.07%
194,687
-161
-0.1% -$16.7K
BSCK
11
DELISTED
Invesco BulletShares 2020 Corporate Bond ETF
BSCK
$20.5M 2.06%
968,001
+13,206
+1% +$279K
AGN
12
DELISTED
Allergan plc
AGN
$19M 1.9%
129,796
-316
-0.2% -$45.8K
XOM icon
13
ExxonMobil
XOM
$651B
$18.1M 1.81%
223,487
-974
-0.4% -$74.3K
Y
14
DELISTED
Alleghany Corp
Y
$17.5M 1.75%
28,580
+17,425
+156% +$10.9M
JPM icon
15
JPMorgan Chase
JPM
$939B
$17.3M 1.73%
171,132
-36,333
-18% -$3.74M
CTRA
16
DELISTED
Coterra Energy
CTRA
$16.8M 1.68%
644,698
-48,603
-7% -$1.22M
QCOM icon
17
Qualcomm
QCOM
$176B
$16.4M 1.65%
288,282
-918
-0.3% -$49.6K
TMO icon
18
Thermo Fisher Scientific
TMO
$211B
$16M 1.6%
58,559
-133
-0.2% -$33.1K
BWA icon
19
BorgWarner
BWA
$13.2B
$15.6M 1.56%
461,459
+75,433
+20% +$2.61M
BSCM
20
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
$15.2M 1.52%
719,602
+16,269
+2% +$340K
AMGN icon
21
Amgen
AMGN
$203B
$15.2M 1.52%
79,900
-1,677
-2% -$320K
MET icon
22
MetLife
MET
$61B
$14.2M 1.42%
332,897
-14,385
-4% -$636K
LEN icon
23
Lennar Class A
LEN
$20.4B
$14M 1.41%
295,530
+46
+0% +$2.08K
MSFT icon
24
Microsoft
MSFT
$2.84T
$13.7M 1.38%
116,503
-48,207
-29% -$5.26M
WD icon
25
Walker & Dunlop
WD
$1.65B
$13.5M 1.35%
265,440
-10,930
-4% -$555K

Similar funds

Shufro Rose & Co's Q1 2019 Portfolio in Review

As of Q1 2019, Shufro Rose & Co held 322 positions worth $999M, up 10% from $905M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Shufro Rose & Co's Q1 2019 filing shows 24 new, 68 increased, 124 reduced and 23 closed positions. Its largest new stake was Tivo Inc: 120,870 shares worth $1.13M. The largest sale was Cisco, an estimated $17.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Shufro Rose & Co's largest Q1 2019 buy was Tivo Inc: 120,870 shares worth $1.13M.
  • Shufro Rose & Co added most to Invesco S&P 500 Equal Weight ETF in Q1 2019, an estimated $39.6M increase.
  • Shufro Rose & Co's biggest Q1 2019 reduction was Cisco, cutting an estimated $17.3M.
  • Shufro Rose & Co fully exited Core Laboratories in Q1 2019, selling an estimated $1.55M.
  • Shufro Rose & Co's ten largest holdings make up 34% of its $999M portfolio in Q1 2019.
  • Shufro Rose & Co opened 24 new positions and closed 23 in Q1 2019.
  • Shufro Rose & Co's portfolio value rose 10% quarter-over-quarter to $999M.

Based on Shufro Rose & Co's 13F filing for Q1 2019, filed 3 May 2019.